The Development of a Sustainable, Province-Wide Model of Care for Cancer Prevention in Women at High-Risk for Breast Cancer
为乳腺癌高危女性制定可持续的全省癌症预防护理模式
基本信息
- 批准号:360953
- 负责人:
- 金额:$ 1.35万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2016
- 资助国家:加拿大
- 起止时间:2016-10-01 至 2017-10-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In Ontario alone, approximately 5500 high risk women receive negative BRCA genetic test results on an annual basis. These women have an elevated risk of developing breast cancer (40% versus 11% in the average woman). High-risk women are given recommendati
仅在安大略省,每年约有5500名高风险妇女接受BRCA基因检测结果为阴性。这些女性患乳腺癌的风险较高(40%,而普通女性为11%)。对高危妇女给予建议
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Metcalfe Kelly A其他文献
Metcalfe Kelly A的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Metcalfe Kelly A', 18)}}的其他基金
Understanding the Effectiveness of Breast Cancer Treatments on Health Outcomes in Women with Germline ATM Mutations
了解乳腺癌治疗对携带种系 ATM 突变的女性健康结果的有效性
- 批准号:
478221 - 财政年份:2023
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
Increasing Uptake of Cascade Genetic Testing in At-Risk Family Members
高危家庭成员越来越多地采用级联基因检测
- 批准号:
468057 - 财政年份:2022
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
Outcomes Associated with Direct Rapid Genetic Testing at Time of Breast Cancer Diagnosis
乳腺癌诊断时直接快速基因检测的相关结果
- 批准号:
437753 - 财政年份:2020
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
Outcomes Associated with Direct Rapid Genetic Testing at Time of Breast Cancer Diagnosis
乳腺癌诊断时直接快速基因检测的相关结果
- 批准号:
414020 - 财政年份:2019
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
Genetic Testing in Females with Ovarian Cancer: Impact of Reflexive Tumour Genetic Testing on Clinical Care
女性卵巢癌基因检测:反射性肿瘤基因检测对临床护理的影响
- 批准号:
415541 - 财政年份:2019
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
Cancer Prevention in Women with a BRCA1 or BRCA2 Mutation: A Follow-up Genetic Counselling Telephone Intervention (PREVENT Trial)
具有 BRCA1 或 BRCA2 突变的女性的癌症预防:后续遗传咨询电话干预(PREVENT 试验)
- 批准号:
304511 - 财政年份:2014
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
Rapid Genetic Testing for BRCA1 and BRCA2 in Newly Diagnosed Breast Cancer Patients
新诊断乳腺癌患者的 BRCA1 和 BRCA2 快速基因检测
- 批准号:
266546 - 财政年份:2012
- 资助金额:
$ 1.35万 - 项目类别:
Operating Grants
相似海外基金
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)
芝加哥不同高危女性人群乳腺癌替代预防研究 (CAPSBRACA)
- 批准号:
10737279 - 财政年份:2023
- 资助金额:
$ 1.35万 - 项目类别:
Leveraging high-risk populations for precision prevention: A novel approach for improving risk prediction for outcomes after a breast cancer diagnosis
利用高危人群进行精准预防:一种改善乳腺癌诊断后结果风险预测的新方法
- 批准号:
10673591 - 财政年份:2022
- 资助金额:
$ 1.35万 - 项目类别:
Spatially informed interrogation of the high-risk breast for breast cancer prevention
对高风险乳房进行空间知情询问以预防乳腺癌
- 批准号:
473970 - 财政年份:2022
- 资助金额:
$ 1.35万 - 项目类别:
Fellowship Programs
Leveraging high-risk populations for precision prevention: A novel approach for improving risk prediction for outcomes after a breast cancer diagnosis
利用高危人群进行精准预防:一种改善乳腺癌诊断后结果风险预测的新方法
- 批准号:
10300319 - 财政年份:2022
- 资助金额:
$ 1.35万 - 项目类别:
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women
支持高危女性个性化乳腺癌预防和早期检测的模拟模型研究
- 批准号:
10201836 - 财政年份:2021
- 资助金额:
$ 1.35万 - 项目类别:
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women
支持高危女性个性化乳腺癌预防和早期检测的模拟模型研究
- 批准号:
10371141 - 财政年份:2021
- 资助金额:
$ 1.35万 - 项目类别:
IBIS II: A randomised phase III trial of anastrozole for breast cancer prevention in postmenopausal women at high risk.
IBIS II:一项阿那曲唑用于预防高危绝经后女性乳腺癌的随机 III 期试验。
- 批准号:
nhmrc : 569213 - 财政年份:2009
- 资助金额:
$ 1.35万 - 项目类别:
NHMRC Project Grants
Breast Cancer Prevention by Letrozole in High Risk Women
高危女性来曲唑预防乳腺癌
- 批准号:
7263372 - 财政年份:2007
- 资助金额:
$ 1.35万 - 项目类别:
Breast Cancer Prevention by Letrozole in High Risk Women
高危女性来曲唑预防乳腺癌
- 批准号:
7687969 - 财政年份:2007
- 资助金额:
$ 1.35万 - 项目类别:
Breast Cancer Prevention by Letrozole in High Risk Women
高危女性来曲唑预防乳腺癌
- 批准号:
7498535 - 财政年份:2007
- 资助金额:
$ 1.35万 - 项目类别: